Literature DB >> 1576098

Acute effects of cyclosporin and cremophor EL on endothelial function and vascular smooth muscle in the isolated rat heart.

P Mankad1, J Spatenka, Z Slavik, G O'Neil, A Chester, M Yacoub.   

Abstract

We studied the effects of cyclosporin dissolved in the vehicle used as an intravenous preparation, namely, cremophor EL, and cremophor alone on the basal coronary flow plus endothelial function and vascular smooth muscle response by examining their influence on 5-hydroxytryptamine (5-HT) and nitroglycerine (GTN) induced the changes in coronary flow in the isolated rat heart. A total of 72 rat hearts were perfused with a modified Langendorf preparation. There was a 12.8 +/- 3% reduction in the basal coronary flow after 60 minutes of perfusion with the drug-free buffer (p = ns). A dose of 50 ng/ml of cremophor or cyclosporin gave a similar reduction in the flow (cremophor 9.2 +/- 0.7%, cyclosporin 12.7 +/- 2%). However, at higher concentrations cremophor caused dose-dependent coronary vasodilation, while cyclosporin had the opposite effect. The maximum effect after 1000 ng/ml of cyclosporin was a 48.7 +/- 0.6% decrease, and after an equivalent dose of cremophor a 24.8 +/- 2.2% increase in the flow. The vasodilatory response to 5-HT and GTN remained unchanged after 60 minutes of perfusion with the drug-free buffer (5-HT, before 33.3 +/- 2.5%, after 37.7 +/- 4.2%; GTN, before 34.3 +/- 2.5%, after 33.7 +/- 1.5%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576098     DOI: 10.1007/bf00050920

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  33 in total

1.  Cyclosporine in vitro reduces endothelium-dependent relaxation to acetylcholine but does not affect relaxation to nitrovasodilators.

Authors:  A T Dinh Xuan; T P Fan; T W Higenbottam; J Wallwork
Journal:  Transplant Proc       Date:  1990-08       Impact factor: 1.066

2.  Ciclosporin A inhibits endothelium-dependent vasodilatation and vascular prostacyclin production.

Authors:  C Bossaller; U Förstermann; R Hertel; C Olbricht; V Reschke; E Fleck
Journal:  Eur J Pharmacol       Date:  1989-06-08       Impact factor: 4.432

3.  The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

4.  Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system.

Authors:  M Bellet; C Cabrol; P Sassano; P Léger; P Corvol; J Ménard
Journal:  Am J Cardiol       Date:  1985-12-01       Impact factor: 2.778

5.  Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.

Authors: 
Journal:  Clin Nephrol       Date:  1985-09       Impact factor: 0.975

6.  Removal of the endothelium potentiates canine large coronary artery constrictor responses to 5-hydroxytryptamine in vivo.

Authors:  K G Lamping; M L Marcus; W P Dole
Journal:  Circ Res       Date:  1985-07       Impact factor: 17.367

7.  Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: analysis of various components in cremophor El and development of a compound with reduced toxicity.

Authors:  W Lorenz; A Schmal; H Schult; S Lang; C Ohmann; D Weber; B Kapp; L Lüben; A Doenicke
Journal:  Agents Actions       Date:  1982-04

8.  Mechanism of cyclosporine A-induced renal vasoconstriction in the rat.

Authors:  N F Rossi; P C Churchill; F D McDonald; V R Ellis
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

9.  Improved immunosuppression for heart transplant patients using intravenous doses of cyclosporine.

Authors:  M P Macris; O H Frazier; C T Van Buren; D E Lammermeier; B D Kahan
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939

10.  Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.

Authors:  H Shulman; G Striker; H J Deeg; M Kennedy; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.